Filings (90d)
1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey Oram files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Milton C. Ault III - $220K in ALZN purchases and sales in the last 12 months
- Lynne Fahey McGrath - $69 in ALZN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey Oram?
Jeffrey Oram is a corporate insider, tracked as Director of Alzamend Neuro, Inc. (ALZN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeffrey Oram submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.